19 June 2013
Keywords: neurosearch, depression, drug, key, future, success, danish
Article | 08 September 1999
Danish biopharmaceutical company NeuroSearch is highlighting NS2389 fordepression as its lead program, following a year in which it has seen ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.